Disc Medicine, Inc.
IRON
$59.79
$0.3750.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 15.09M | 12.18M | 9.75M | 8.17M | 7.37M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 61.41M | 39.95M | 34.55M | 32.86M | 30.85M |
Operating Income | -61.41M | -39.95M | -34.55M | -32.86M | -30.85M |
Income Before Tax | -55.20M | -33.97M | -29.28M | -26.49M | -26.29M |
Income Tax Expenses | 52.00K | 119.00K | 176.00K | 114.00K | 60.00K |
Earnings from Continuing Operations | -55.25M | -34.09M | -29.46M | -26.60M | -26.35M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -55.25M | -34.09M | -29.46M | -26.60M | -26.35M |
EBIT | -61.41M | -39.95M | -34.55M | -32.86M | -30.85M |
EBITDA | -61.33M | -39.93M | -34.54M | -32.85M | -30.74M |
EPS Basic | -1.58 | -1.02 | -0.98 | -0.89 | -1.03 |
Normalized Basic EPS | -0.98 | -0.64 | -0.61 | -0.55 | -0.64 |
EPS Diluted | -1.58 | -1.02 | -0.98 | -0.89 | -1.03 |
Normalized Diluted EPS | -0.98 | -0.64 | -0.61 | -0.55 | -0.64 |
Average Basic Shares Outstanding | 35.02M | 33.32M | 30.00M | 29.94M | 25.65M |
Average Diluted Shares Outstanding | 35.02M | 33.32M | 30.00M | 29.94M | 25.65M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |